arrow
A

Antonio Magnano

azienda ospedaliera universitaria policlinico vittorio emanuele presidio ferraotto
H指数:16
被引数:1,029

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy of 1 L polyethylene glycol plus ascorbate versus 4 L polyethylene glycol in split-dose for colonoscopy cleansing in out and inpatient: A multicentre, randomized trial (OVER 2019)
2024-03-012
PRE
Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease
2022-05-019
PRE
SPOSAB ABP 501: A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501

SPOSAB ABP 501: 阿达木单抗生物仿制药ABP 501治疗炎症性肠病患者的西西里前瞻性观察研究

2021-07-0319
PREAI
SPOSAB ABP 501-A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501
2021-05-270
PRE
Effectiveness of Ustekinumab on Crohn's disease associated spondyloartropathy: real-world data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)
2021-05-270
PRE
A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis

维多珠单抗、阿达木单抗和戈利木单抗在溃疡性结肠炎患者中的倾向评分加权比较

2020-12-0120
PREAI
Effectiveness of Ustekinumab on Crohn's Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)
2020-10-0911
PREAI
A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis

阿达木单抗和戈利木单抗在中度至重度溃疡性结肠炎中的有效性的现实生活比较,由倾向评分分析支持

2018-12-0119
PREAI
A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naive and Non-naive Patients With Crohn's Disease: Real-Life Data From the Sicilian Network for Inflammatory Bowel Disease
2018-10-0631
PREAI
The real-world effectiveness of vedolizumab on intestinal and articular outcomes in inflammatory bowel diseases

维多珠单抗在炎症性肠病中对肠道和关节结局的真实效果

2018-07-0136
PREAI
THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD): A COMPARISON OF THE EFFICACY OF CURRENT BIOLOGICS IN CROHN'S DISEASE
2018-03-010
PREAI
A REAL LIFE COMPARISON OF THE EFFECTIVENESS OF ADALIMUMAB VERSUS GOLIMUMAB IN MODERATE-TO-SEVERE ULCERATIVE COLITIS. A MULTICENTRE EXPERIENCE FROM A REGIONAL NETWORK FOR INFLAMMATORY BOWEL DISEASE
2018-03-010
PREAI
THE SICILIAN NETWORK OF BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE: PRELIMINARY DATA FROM A PROSPECTIVE STUDY ON EFFICACY AND SAFETY
2017-03-010
PREAI